The motion has passed. We will arrange for the summons to be created.
I don't recall if a date or time was specified, but I think it will be a time determined by the chair. We will get that under way and report back to the committee when that occurs.
I would now like to welcome our witnesses.
As an individual, we have Dr. Robert Fowler, professor of medicine and program director of clinical epidemiology and health care research at the Dalla Lana School of Public Health, University of Toronto. From the Canadian Society for Molecular Biosciences, we have Dr. Tarik Möröy. From Genome Canada, we have Dr. Rob Annan and Dr. Cindy Bell. Dr. Annan is president and CEO. Dr. Bell is executive vice-president, corporate development. From VIDO-InterVac, we have Dr. Volker Gerdts, director and chief executive officer, and Dr. Paul Hodgson, associate director, business development.
We will start with Dr. Fowler for 10 minutes. Please, go ahead with your statement.